Suchergebnisse - "Seiffert, Martina"

PubPharm (8)

1

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels

enthalten in: Nature cell biology | 2020

von Roider, T. | Seufert, J. | Uvarovskii, A. | +23

2

Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment : What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

enthalten in: Frontiers in immunology | 2020

von Aydin, E. | Faehling, S. | Saleh, M. | +3

3

Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia

enthalten in: Leukemia | 2020

von Giménez, N. | Schulz, R. | Higashi, M. | +9

4

IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia

enthalten in: Blood | 2019

von Scheffold, A. | Jebaraj, B. | Tausch, E. | +17

CommentIn: Blood. 2019 Aug 8;134(6):496-498. - PMID 31395581

5

PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia

enthalten in: Leukemia | 2019

von Hanna, B. | Roessner, P. | Scheffold, A. | +6

6

BRAF inhibition in hairy cell leukemia with low-dose vemurafenib

enthalten in: Blood | 2016

von Dietrich, S. | Pircher, A. | Endris, V. | +25

CommentIn: Blood. 2016 Jun 9;127(23 ):2784-5. - PMID 27282942

7

Isolation, structural analyses and biological activity assays against chronic lymphocytic leukemia of two novel cytochalasins - sclerotionigrin A and B

enthalten in: Molecules (Basel, Switzerland) | 2014

von Petersen, L. | Bladt, T. | Dürr, C. | +4

8

Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment

enthalten in: Blood | 2013

von Schulz, A. | Dürr, C. | Zenz, T. | +4

1
[1]